An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

Библиографические подробности
Главные авторы:	Campa, D, Kaaks, R, Le Marchand, L, Haiman, C, Travis, R, Ziegler, R, Hunter, D, Lindstroem, S, Canzian, F
Формат:	Conference item
Опубликовано:	2012

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Tsilidis, K, и др.
Опубликовано: (2013)

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Lindström, S, и др.
Опубликовано: (2012)

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Ahn, J, и др.
Опубликовано: (2009)

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Setiawan, V, и др.
Опубликовано: (2007)

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Cox, D, и др.
Опубликовано: (2006)

Genetic polymorphisms of the <it>GNRH1 </it>and <it>GNRHR </it>genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
по: Lund Eiliv, и др.
Опубликовано: (2009-07-01)

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
по: Patel, A, и др.
Опубликовано: (2008)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium
по: Campa, D, и др.
Опубликовано: (2011)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
по: Campa, D, и др.
Опубликовано: (2011)

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
по: Mondul, A, и др.
Опубликовано: (2013)

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
по: Barrdahl, M, и др.
Опубликовано: (2014)

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
по: Joshi, A, и др.
Опубликовано: (2014)

Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
по: Machiela, M, и др.
Опубликовано: (2012)

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
по: Chen, Y, и др.
Опубликовано: (2007)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
по: Lindstrom, S, и др.
Опубликовано: (2011)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
по: Shui, I, и др.
Опубликовано: (2014)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
по: Lindström, S, и др.
Опубликовано: (2010)

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
по: Travis, R, и др.
Опубликовано: (2009)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
по: Shui, I, и др.
Опубликовано: (2014)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
по: Sara Lindstrom, и др.
Опубликовано: (2011-02-01)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
по: Mathew, Angelin Tresa, и др.
Опубликовано: (2022)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
по: Mathew, Angelin T., и др.
Опубликовано: (2022)

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
по: Agarwal, D, и др.
Опубликовано: (2014)

Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
по: Tsilidis, K, и др.
Опубликовано: (2012)

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
по: Milne, R, и др.
Опубликовано: (2014)

Characteristics of Breast Cancer at First Presentation in Sudanese Patients Attending the National Cancer Institute–University of Gezira (NCI–UG)
по: Muna Ahmed Eltayeb, и др.
Опубликовано: (2020-08-01)

Haplotypes of the estrogen receptor beta gene and breast cancer risk.
по: Cox, D, и др.
Опубликовано: (2008)

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
по: Koutros, S, и др.
Опубликовано: (2010)

Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198
по: Anna D. Cirac, и др.
Опубликовано: (2017-06-01)

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
по: Yang, X, и др.
Опубликовано: (2011)

Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women
по: Carolyn Nickson, и др.
Опубликовано: (2018-12-01)

Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.
по: Jirong Long, и др.
Опубликовано: (2010-06-01)

A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
по: Schumacher, F, и др.
Опубликовано: (2007)

The role of osteoprotegerin in breast and prostate cancer
по: Holen, I, и др.
Опубликовано: (2002)

The impact of transcription on metabolism in prostate and breast cancers
по: Poulose, N, и др.
Опубликовано: (2018)

Frequency of breast cancer subtypes among African American women in the AMBER consortium
по: Emma H. Allott, и др.
Опубликовано: (2018-02-01)

The Prostate Cancer Research Consortium Bioresource (Ireland)
по: Antony Wekesa, и др.
Опубликовано: (2016-11-01)

Nutrition and breast cancer.
по: Key, T, и др.
Опубликовано: (2003)

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
по: Foluso O. Ademuyiwa, и др.
Опубликовано: (2022-12-01)

An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

Схожие документы

Схожие документы